With this study, we hope to find out how safe and effective a new treatment is for helping adults with moderate to severe plaque psoriasis. Our goal is to understand how the treatment works over the long term. This study includes two parts: Part A involves new participants who haven't been in our earlier studies, while Part B includes those who have completed Part A or have been part of our earlier studies.
You'll be part of a study helping us understand and improve treatments for plaque psoriasis. Over time, you'll take a daily tablet that could help manage your symptoms. In this study, you'll participate for either about 1 year or up to 3 years, depending on which part you join. You'll answer some questionnaires and have tests like blood and urine samples. There'll also be an EKG and Chest X-ray, a physical exam, and we'll take some photos. You'll also wear a device to help us track your progress. All these will help us learn more about the treatment's effects.
Dermatology Clinical Trials Unit (DCTU)
UNC Dermatology and Skin Cancer Center at Southern Village
410 Market St Ste 362, Chapel Hill, NC 27516, USA
Laura Ferris
Dermatology-Research
Clinical or Medical
Interventional
Skin, Hair, and Nails
25-2471
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
